Waghorn Ben, Edwards Tiffany, Yang Yuhui, Chuang Kai-Hsiang, Yanasak Nathan, Hu Tom C-C
Small Animal Imaging, Department of Radiology, Medical College of Georgia, Augusta, GA 30912, USA.
NMR Biomed. 2008 Nov;21(10):1102-11. doi: 10.1002/nbm.1287.
Manganese has been used as a T(1)-weighted MRI contrast agent in a variety of applications. Because manganese ions (Mn(2+)) enter viable myocardial cells via voltage-gated Ca(2+) channels, manganese-enhanced MRI is sensitive to the viability and inotropic state of the heart. In spite of the established importance of Ca(2+) regulation in the heart both before and after myocardial injury, monitoring strategies to assess Ca(2+) homeostasis in affected cardiac tissues are limited. This study implements a T(1)-mapping method to obtain quantitative information both dynamically and over a range of MnCl(2) infusion doses. To optimize the current Mn(2+) infusion protocols, we performed both dose-dependent and temporal washout studies. A non-linear relationship between infused MnCl(2) solution dose and increase in left ventricular wall relaxation rate (DeltaR(1)) was observed. Control mice also exhibited significant Mn(2+) clearance over time, with a decrease in DeltaR(1) of approximately 50% occurring in just 2.5 h. The complicated efflux time dependence possibly suggests multiple efflux mechanisms. With the use of the measured relationship between infused Mn(2+) dose, DeltaR(1), and inductively coupled plasma mass spectrometry data analysis provided a means of estimating the absolute heart Mn concentration in vivo. We show that this technique has the sensitivity to observe or monitor potential alterations in Ca(2+) handling in vivo because of the physiological remodeling after myocardial infarction. Left ventricular free wall DeltaR(1) values were significantly lower (P = 0.005) in the adjacent zone, surrounding the injured myocardial tissue, than in healthy tissue. This inferred reduction in Mn concentration can be used to estimate potentially salvageable myocardium in vivo for future treatment or evaluation of disease progression.
锰已在多种应用中用作T(1)加权磁共振成像(MRI)造影剂。由于锰离子(Mn(2+))通过电压门控钙通道(Ca(2+))进入存活的心肌细胞,锰增强MRI对心脏的活力和变力状态敏感。尽管心肌损伤前后钙调节在心脏中已确立的重要性,但评估受影响心脏组织中钙稳态的监测策略有限。本研究采用T(1)映射方法,以动态方式并在一系列氯化锰输注剂量范围内获取定量信息。为了优化当前的Mn(2+)输注方案,我们进行了剂量依赖性和时间洗脱研究。观察到输注的氯化锰溶液剂量与左心室壁松弛率增加(DeltaR(1))之间存在非线性关系。对照小鼠也随着时间推移表现出显著的锰清除,仅在2.5小时内DeltaR(1)就下降了约50%。复杂的流出时间依赖性可能提示多种流出机制。利用测量的输注锰剂量、DeltaR(1)之间的关系以及电感耦合等离子体质谱数据分析,提供了一种估计体内心脏绝对锰浓度的方法。我们表明,由于心肌梗死后的生理重塑,该技术具有观察或监测体内钙处理潜在变化的敏感性。受损心肌组织周围相邻区域的左心室游离壁DeltaR(1)值显著低于健康组织(P = 0.005)。这种推断的锰浓度降低可用于估计体内潜在可挽救的心肌,以供未来治疗或疾病进展评估。